{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:48:55Z","timestamp":1792691335774,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008078","name":"University of Strathclyde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["10058505"],"award-info":[{"award-number":["10058505"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejpb.2025.114726","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:15:16Z","timestamp":1745558116000},"page":"114726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance"],"prefix":"10.1016","volume":"212","author":[{"given":"Ankita","family":"Borah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Giacobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Binici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranald","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Perrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","article-title":"Lipid-based nanotherapeutics for siRNA delivery","volume":"267","author":"Schroeder","year":"2010","journal-title":"J Intern Med."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114726_b0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114726_b0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The Importance of Apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol Sci."},{"issue":"27","key":"10.1016\/j.ejpb.2025.114726_b0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ejpb.2025.114726_b0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2025.114726_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065944","article-title":"mRNA Vaccines against SARS-CoV-2: Advantages and Caveats","author":"Echaide","year":"2023","journal-title":"Int J Mol Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114726_b0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F Protein Vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114726_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Mendon\u00e7a","year":"2023","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.ejpb.2025.114726_b0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.ejpb.2025.114726_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202300006","article-title":"Ionizable Lipid Nanoparticles for mRNA Delivery","author":"Tang","year":"2023","journal-title":"Adv Nanobiomed Res."},{"issue":"12","key":"10.1016\/j.ejpb.2025.114726_b0055","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of Polyethylene Glycol Lipid Desorption Rates on pharmacokinetics and pharmacodynamics of siRNA Lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol Ther Nucleic Acids."},{"issue":"12","key":"10.1016\/j.ejpb.2025.114726_b0060","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","volume":"11","author":"Waggoner","year":"2023","journal-title":"Biomater Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114726_b0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/mp500400k","article-title":"Real Time Measurement of PEG Shedding from lipid nanoparticles in serum via NMR Spectroscopy","volume":"12","author":"Wilson","year":"2015","journal-title":"Mol Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114726_b0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted Delivery of RNAi Therapeutics With endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114726_b0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.15585\/mmwr.mm7111a4","volume":"71","author":"Wallace","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and Non-linear Gene Expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2025.114726_b0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","article-title":"Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined in vitro and preclinical perspective","volume":"377","author":"Binici","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114726_b0095","doi-asserted-by":"crossref","unstructured":"Binici B, Borah A, Watts JA, McLoughlin D, Perrie Y. The influence of citrate buffer molarity in mRNA-LNPs: Exploring factors beyond general critical quality attributes. Int J Pharm. 2024 Nov;124942.","DOI":"10.1016\/j.ijpharm.2024.124942"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114726_b0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun Biol."},{"key":"10.1016\/j.ejpb.2025.114726_b0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtn.2021.03.008","article-title":"Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein","volume":"24","author":"Davies","year":"2021","journal-title":"Mol Ther Nucleic Acids."},{"key":"10.1016\/j.ejpb.2025.114726_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int J Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J Nanobiotechnology."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114726_b0125","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/pharmaceutics12111068","article-title":"The Importance of Poly(ethylene glycol) and Lipid Structure in targeted gene delivery to lymph nodes by lipid nanoparticles","volume":"12","author":"Zukancic","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2025.114726_b0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","article-title":"Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection","volume":"325","author":"Lou","year":"2020","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114726_b0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2025.114726_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119266","article-title":"Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: a case study using protein-loaded liposomes","volume":"582","author":"Webb","year":"2020","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2025.114726_b0145","doi-asserted-by":"crossref","unstructured":"Roces CB, Lou G, Jain N, Abraham S, Thomas A, Halbert GW, et al. Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics. Pharmaceutics [Internet]. 2020 Nov 1 [cited 2023 May 2];12(11):1\u201319. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33203082\/.","DOI":"10.3390\/pharmaceutics12111095"},{"issue":"12","key":"10.1016\/j.ejpb.2025.114726_b0150","article-title":"The Impact of Solvent Selection: Strategies to Guide the manufacturing of liposomes using microfluidics","volume":"11","author":"Webb","year":"2019","journal-title":"Pharmaceutics [internet]."},{"key":"10.1016\/j.ejpb.2025.114726_b0155","doi-asserted-by":"crossref","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","author":"McMillan","year":"2024","journal-title":"RSC Pharmaceutics."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114726_b0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.apsb.2021.02.019","article-title":"Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers","volume":"11","author":"Mazumdar","year":"2021","journal-title":"Acta Pharm Sin b."},{"issue":"12","key":"10.1016\/j.ejpb.2025.114726_b0165","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114726_b0170","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","article-title":"Lipid Nanoparticle-Mediated Delivery of mRNA therapeutics and vaccines","volume":"27","author":"Swingle","year":"2021","journal-title":"Trends Mol Med."},{"key":"10.1016\/j.ejpb.2025.114726_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdev.2021.203713","article-title":"Macropinocytosis: biology and mechanisms","volume":"168","author":"Kay","year":"2021","journal-title":"Cells Dev."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114726_b0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/pharmaceutics13050761","article-title":"Endocytic uptake of solid lipid nanoparticles by the nasal mucosa","volume":"13","author":"Al Khafaji","year":"2021","journal-title":"Pharmaceutics."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114726_b0185","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ymthe.2019.07.018","article-title":"Endocytic profiling of cancer cell models reveals critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression","volume":"27","author":"Sayers","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2025.114726_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115065","article-title":"In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy","volume":"165","author":"Escalona-Rayo","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114726_b0195","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114726_b0200","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat Commun."},{"key":"10.1016\/j.ejpb.2025.114726_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202105832","article-title":"Mechanistic Studies of an automated lipid nanoparticle reveal critical pharmaceutical properties associated with enhanced mRNA functional delivery in vitro and in vivo","author":"Cui","year":"2022","journal-title":"Small"},{"issue":"24","key":"10.1016\/j.ejpb.2025.114726_b0210","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1021\/acs.nanolett.2c03741","article-title":"The Extent to Which Lipid nanoparticles require apolipoprotein e and low-density lipoprotein Receptor for Delivery Changes with Ionizable Lipid Structure","volume":"22","author":"Paunovska","year":"2022","journal-title":"Nano Lett."},{"issue":"16","key":"10.1016\/j.ejpb.2025.114726_b0215","doi-asserted-by":"crossref","first-page":"10583","DOI":"10.1016\/S0021-9258(18)99263-X","article-title":"Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content","volume":"266","author":"Zechner","year":"1991","journal-title":"J Biol Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:40:02Z","timestamp":1762332002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"alternative-id":["S0939641125001031"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114726","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114726"}}